Can Gut Bacteria Be The Key To Banishing Forever Chemicals?
PFAS (Perfluoroalkyl and Polyfluoroalkyl Substances) have been shown to cause health issues like decreased fertility, cardiovascular disease, developmental delays in children, and increased risk of certain cancers. Now, researchers say a microbe naturally found in the human gut may be able to absorb these forever chemicals and help remove them from the body.
The researchers introduced nine of these bacterial species into the guts of mice in an attempt to 'humanize' the rodents' microbiomes. They found that the bacteria quickly absorbed PFAS that were consumed by the mice, which were then expelled in their feces.
Notably, as more and more PFAS were introduced, the microbes worked harder, consistently helping withdraw the same percentage of the chemicals. Within just minutes of PFAS exposure, the bacteria accumulated between 25% and 74% of the chemicals.
While the findings are promising, the results have yet to be verified in humans. The researchers aim to utilize the study's findings to develop probiotic dietary supplements that can enhance the levels of these microbes in the human gut.
In May, The Dallas Express reported that the Environmental Protection Agency announced it would roll back limitations on certain PFAS in drinking water. Standards for PFOA and PFOS, two primary subtypes of PFAS, will remain at four parts per trillion; however, utilities will be given an extension to 2031 to comply with the limitation.
Despite the health risks associated with PFAS, they remain ubiquitous in human environments, found in a wide range of products, including food packaging, waterproof clothing, and non-stick pans. Since they take thousands of years to break down, these forever chemicals continue to accumulate in both the environment and human bodies.
'Given the scale of the problem of PFAS 'forever chemicals', particularly their effects on human health, it's concerning that so little is being done about removing these from our bodies,' said Dr. Kiran Patil, of the University of Cambridge's MRC Toxicology Unit and senior author of the report.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
34 minutes ago
- Fox News
Stanford scientists 'totally surprised' by potential Parkinson's treatment discovery
A recent study from Stanford Medicine that "totally surprised" researchers highlighted what could be a promising approach to slowing Parkinson's disease progression. The research, published in the journal Science Signaling, took a closer look at enzymes — proteins in the body that speed up chemical reactions and are essential for digestion, liver function and other key functions, according to Cleveland Clinic — and their role in Parkinson's. The team found that targeting a certain enzyme helped to restore neuron and cell communication in mice. Lead author Suzanne Pfeffer, PhD, the Emma Pfeiffer Merner Professor in Medical Sciences and a professor of biochemistry at Stanford, told Fox News Digital that the team was "totally surprised that we saw as much improvement as we did." In about 25% of Parkinson's cases, the culprit is some form of genetic mutation. One of the most common mutations creates an overactive enzyme called LRRK2, according to a Stanford press release. When there is too much LRRK2 activity, it changes the structure of the brain cells, disrupting important communication between neurons and cells. This system is crucial to movement, motivation and decision-making, according to the researchers. The goal of the study was to determine whether a specific molecule — the MLi-2 LRRK2 kinase inhibitor — could reverse the effect of overactive enzymes. Using mice that had the genetic mutation that causes overactive LRRK2 and also had symptoms consistent with early Parkinson's disease, the scientists tried feeding them the inhibitor for two weeks. There were initially no changes detected in brain structure, signaling or function of the dopamine neurons. However, after three months of eating the inhibitor, mice affected by the overactive enzyme appeared to have restored their neurons to the point where they were virtually the same as those without the genetic mutation, the study found. "Findings from this study suggest that inhibiting the LRRK2 enzyme could stabilize the progression of symptoms if patients can be identified early enough," Pfeffer said in the press release. The study did have some limitations, the researchers acknowledged. "This was in mice, not people, but our current results indicate that similar pathways are important in humans," Pfeffer told Fox News Digital. While the study focused on a specific genetic form of the disease, overactive LRRK2 is also present in other cases, meaning this treatment could help multiple types of Parkinson's patients and possibly those with other neurodegenerative diseases, the reseachers claimed. Looking ahead, the team plans to investigate whether other forms of Parkinson's could benefit. Parkinson's — a disease that involves the slow death of dopamine-producing neurons, leading to symptoms like tremors and stiffness — affects nearly one million Americans, according to the Parkinson's Foundation, which has offices in New York and Miami. Experts agree that early intervention is key, as Parkinson's symptoms often appear years after the disease begins. "These findings suggest that it might be possible to improve, not just stabilize, the condition of patients with Parkinson's disease." Identifying and treating at-risk individuals sooner could potentially halt or reverse neuron loss. "These findings suggest that it might be possible to improve, not just stabilize, the condition of patients with Parkinson's disease," Pfeffer said. For more Health articles, visit The researcher told Fox News Digital that it's important to encourage patients to undergo genetic testing to learn more about their suitability for clinical trials and future treatments. The study was funded by The Michael J. Fox Foundation for Parkinson's Research, the Aligning Science Across Parkinson's initiative and the United Kingdom Medical Research Council.
New York Times
34 minutes ago
- New York Times
Franklin W. Stahl, 95, Dies; Helped Create a ‘Beautiful' DNA Experiment
Franklin W. Stahl, a molecular biologist who helped create a methodology to confirm how DNA replicates that was so elegant it has been remembered for more than five decades as 'the most beautiful experiment in biology,' died on April 2 at his home in Eugene, Ore. He was 95. The cause was congestive heart failure, his son Andy Stahl said. His death was not widely reported at the time, and there was no announcement about it from the University of Oregon in Eugene, where he was a professor and researcher. At his death, Dr. Stahl was an emeritus professor of molecular biology and genetics at the university's Institute of Molecular Biology. He had been at the university since 1959. Dr. Stahl's name and that of his collaborator, Matthew Meselson, were immortalized by the Meselson-Stahl Experiment, which is referenced in biology textbooks and taught in molecular genetics courses worldwide. In 2015, 'Helix Spirals,' a musical tribute to the experiment, was composed by Augusta Read Thomas and performed by a string quartet in Boston. The two biologists proved a theory advanced by the Nobel Prize winners James Watson and Francis Crick, who discovered DNA's helical structure in 1953. Watson and Crick posited in the journal Nature that DNA replicates in a so-called semi-conservative fashion. In 1958, Dr. Meselson and Dr. Stahl, postdoctoral fellows in Linus Pauling's laboratory at the California Institute of Technology in Pasadena, Calif., proved that Watson and Crick were correct, by using an experiment that was celebrated for its design, execution and results. Want all of The Times? Subscribe.
Yahoo
an hour ago
- Yahoo
RFK Jr. promoted a food company he says will make Americans healthy. Their meals are ultraprocessed
WASHINGTON (AP) — Health secretary Robert F. Kennedy Jr. on Monday praised a company that makes $7-a-pop meals that are delivered directly to the homes of Medicaid and Medicare enrollees. He even thanked Mom's Meals for sending taxpayer-funded meals 'without additives" to the homes of sick or elderly Americans. The spreads include chicken bacon ranch pasta for dinner and French toast sticks with fruit or ham patties. 'This is really one of the solutions for making our country healthy again,' Kennedy said in the video, posted to his official health secretary account, after he toured the company's Oklahoma facility last week. But an Associated Press review of Mom's Meals menu, including the ingredients and nutrition labels, shows that the company's offerings are the type of heat-and-eat, ultraprocessed foods that Kennedy routinely criticizes for making people sick. The meals contain chemical additives that would render them impossible to recreate at home in your kitchen, said Marion Nestle, a nutritionist at New York University and food policy expert, who reviewed the menu for The AP. Many menu items are high in sodium, and some are high in sugar or saturated fats, she said. 'It is perfectly possible to make meals like this with real foods and no ultra-processing additives but every one of the meals I looked at is loaded with such additives,' Nestle said. 'What's so sad is that they don't have to be this way. Other companies are able to produce much better products, but of course they cost more.' Mom's Meals do not have the artificial, petroleum dyes that Kennedy has pressured companies to remove from products, she noted. Mom's Meals said in an emailed response that its food products 'do not include ingredients that are commonly found in ultra-processed foods.' The company does not use synthetic food dyes, high fructose corn syrup, certain sweeteners or synthetic preservatives that are banned in Europe, said Teresa Roof, a company spokeswoman. The meals are a 'healthy alternative' to what many people would find in their grocery stores, said Andrew Nixon, U.S. Health and Human Services spokesman, in response to questions about Mom's Meals. Mom's Meals is one of several companies across the U.S. that deliver 'medically tailored' at-home meals. The meal programs are covered by Medicaid for some enrollees, including people who are sick with cancer or diabetes, as well as some older Americans who are enrolled in certain Medicare health insurance plans. Patients recently discharged from the hospital can also have the meals delivered, according to the company's website. It's unclear how much federal taxpayers spend on providing meals through Medicaid and Medicare every year. An investigation by STAT news last year found that some states were spending millions of dollars to provide medically tailored meals to Medicaid enrollees that were marketed as healthy and 'dietician approved." But many companies served up meals loaded with salt, fat or sugar — all staples of an unhealthy American's diet, the report concluded. Defining ultraprocessed foods can be tricky. Most U.S. foods are processed, whether it's by freezing, grinding, fermentation, pasteurization or other means. Foods created through industrial processes and with ingredients such as additives, colors and preservatives that you couldn't duplicate in a home kitchen are considered the most processed. Kennedy has said healthier U.S. diets are key to his vision to 'Make America Healthy Again.' His call for Americans to increase whole foods in their diets has helped Kennedy build his unique coalition of Trump loyalists and suburban moms who have branded themselves as 'MAHA." In a recent social media post where he criticized the vast amount of ultraprocessed foods in American diets, Kennedy urged Americans to make healthier choices. 'This country has lost the most basic of all freedoms — the freedom that comes from being healthy," Kennedy said. — Aleccia reported from Temecula, Calif.
